Novus Biologicals社 Tipping the Scale for Improved Immunotherapies
|
この製品に関するご意見・ご照会・お問合せはこちら
The immune system has a potent anti-tumor response, and the tumor has a potent anti-immune response. Discover how researchers are helping to tip the scale in favor of the anti-tumor immune response.
 |
Live Webinar Exploiting Tumor Hypoxia for Targeted Immunotherapy
Can targeting tumor hypoxia improve immunotherapy?
In the complex landscape of the tumor microenvironment (TME), hypoxia is a common feature as tumor growth often outpaces the blood supply. In our upcoming live webinar learn more about the complex relationship between hypoxia and T cells within the TME and strategies to improve immunotherapy.
 |
 |
The Natural NK Cell Army
NK cells are the emerging cell type for cancer immunotherapies, including chimeric antigen receptor (CAR)-NK cell therapies. Our blog shares perspective on their unique properties and their role in anti-tumor immunotherapy.
 |
|
Fount of Information は、新商品、新規取扱メーカーなどの情報をいち早く紹介するコンテンツです。情報発信のスピードを重視しているコンテンツのため、現時点で法規制や取り扱いを確認できていない商品、定価を設定できていない商品があります。ご要望やご照会を受けた商品について、法令整備や在庫の充実を図ります。
